Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

CSL share price ticks higher — but the real test is Feb 11

CSL share price ticks higher — but the real test is Feb 11

CSL Ltd shares closed up 0.46% at A$175.10 on Monday, with about 376,000 shares traded. The move comes ahead of CSL’s half-year results and interim dividend announcement set for Feb. 11. The S&P/ASX 200 finished 0.48% higher, led by gold and consumer stocks, as spot gold hit a 2026 record. CSL’s outlook remains cautious after last year’s guidance cut and delayed Seqirus spin-off.
12 January 2026
ANZ share price rises after chairman share buy and Australian Open deal; what to watch next

ANZ share price rises after chairman share buy and Australian Open deal; what to watch next

ANZ shares rose 1.2% to A$35.89 Monday, leading Australia’s major banks as the ASX 200 reached its highest since December 24. Chairman Paul O’Sullivan bought 3,300 shares at an average of A$35.92, raising his indirect stake to 39,950. Household spending jumped 1% in November, fueling bets on a possible RBA rate hike. Around 3 million ANZ shares changed hands in steady trading.
12 January 2026
PLS Group (ASX:PLS) stock climbs as China lithium prices hit limit-up — what to watch next

PLS Group (ASX:PLS) stock climbs as China lithium prices hit limit-up — what to watch next

PLS Group shares rose 2.6% to A$4.77 Monday, tracking a sharp jump in China’s lithium carbonate prices, which climbed about 12,000 yuan to 148,000–156,000 yuan per ton. Liontown and Mineral Resources also advanced on the ASX. PLS will release its quarterly update in late January. Australia announced a A$1.2 billion critical minerals reserve, excluding lithium.
Northern Star stock jumps with gold at record highs — what ASX:NST investors watch next

Northern Star stock jumps with gold at record highs — what ASX:NST investors watch next

Northern Star Resources shares closed up 2.9% at A$25.43 on Monday, boosted by record-high gold prices. The company recently cut its FY26 gold sales forecast and warned of rising costs after operational setbacks at several sites. Analysts maintain a “Buy” rating with a 12-month price target near A$28.39. Gold’s rally followed news of a criminal probe involving U.S. Fed Chair Jerome Powell and a weaker U.S. dollar.
Fortescue share price drops as iron ore traders look to China data, quarterly update next

Fortescue share price drops as iron ore traders look to China data, quarterly update next

Fortescue shares fell 1.4% to A$22.40, underperforming the broader market as heavyweight miners dragged the index despite gains in energy and gold stocks. Company filings showed 272,520 new employee performance rights issued and 1,309 lapsed in December. About 4.7 million shares traded, up from Friday. Investors await Fortescue’s quarterly production report on Jan. 22.
12 January 2026
Tri Pointe Homes stock jumps nearly 9% as Trump mortgage-bond order lifts homebuilders; CPI next

Tri Pointe Homes stock jumps nearly 9% as Trump mortgage-bond order lifts homebuilders; CPI next

Tri Pointe Homes shares rose 8.7% to $35.42 Friday after President Trump announced a $200 billion federal purchase of mortgage bonds aimed at lowering rates. Other homebuilder stocks also climbed. RBC Capital lowered its price target for Tri Pointe to $31, citing affordability concerns. December CPI data is due Tuesday.
Eos Energy (EOSE) stock jumps 9% — what to know before Monday’s open

Eos Energy (EOSE) stock jumps 9% — what to know before Monday’s open

Eos Energy shares jumped nearly 9% Friday to $15.28 amid heavy trading and high short interest, outpacing the S&P 500’s record close. The company reported a $641.4 million quarterly loss but reaffirmed its 2025 revenue outlook. Board chair Russell Stidolph stepped down Dec. 31, with Joseph Nigro set to replace him. Investors await new short-interest data Monday and U.S. inflation figures Tuesday.
OLMA stock jumps 10% into JPMorgan week — what to watch for Olema Pharmaceuticals

OLMA stock jumps 10% into JPMorgan week — what to watch for Olema Pharmaceuticals

Olema Pharmaceuticals shares jumped 9.8% to $28.08 Friday, with 2.5 million shares traded ahead of the CEO’s Jan. 13 presentation at the J.P. Morgan Healthcare Conference. Citi, UBS, and Piper Sandler issued bullish ratings and price targets up to $60, citing upcoming trial data and potential catalysts. Olema raised $218.5 million in November. The company has no approved products and is advancing two breast cancer drug candidates.
11 January 2026
Bloom Energy stock heads into Monday after $2.65 billion AEP fuel-cell order sparks fresh analyst split

Bloom Energy stock heads into Monday after $2.65 billion AEP fuel-cell order sparks fresh analyst split

Bloom Energy shares jumped 10.1% to $134.07 Friday after American Electric Power agreed to buy fuel-cell units for a Wyoming data center project valued at $2.65 billion. Analysts split on valuation; Clear Street raised its price target to $68, while BMO set it at $136. The deal includes a 20-year offtake contract. Wyoming officials have promoted the project’s economic impact.
Meritage Homes (MTH) stock pops 10% on Trump mortgage-bond push — what to watch next week

Meritage Homes (MTH) stock pops 10% on Trump mortgage-bond push — what to watch next week

Meritage Homes shares surged 10.4% to $75.45 on Friday after President Trump announced a federal mortgage-bond buying plan targeting lower rates. The Philadelphia Housing index rose 4.8%. Traders now await U.S. inflation data Tuesday and Meritage’s earnings report on Jan. 28. Treasury Secretary Scott Bessent said the bond buying aims to match the Fed’s monthly runoff.
11 January 2026
TTM Technologies (TTMI) stock jumps 10% — what investors watch next week

TTM Technologies (TTMI) stock jumps 10% — what investors watch next week

TTM Technologies shares jumped 10.5% Friday to $73.88, nearing the top of their 52-week range on heavy volume. CEO Edwin Roks and CFO Dan Boehle are scheduled to speak at the Needham Growth Conference in New York on Jan. 13. Investors await updates on data-center demand and new facility ramp-up. Quarterly earnings are expected Feb. 4.
11 January 2026
Regencell Bioscience (RGC) stock swings 45% then closes up 10.6% — what to watch Monday

Regencell Bioscience (RGC) stock swings 45% then closes up 10.6% — what to watch Monday

Regencell Bioscience shares closed Friday up 10.6% at $45.79 after swinging between $35.13 and $50.92 on heavy volume. The company disclosed a DOJ subpoena and warned of possible legal penalties and funding risks in its Oct. 31 annual report. Its auditor expressed “substantial doubt” about Regencell’s ability to continue as a going concern. No new corporate updates have been posted since the annual filing.
1 205 206 207 208 209 535

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026
Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
Go toTop